This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2021 Apr;39(7):2673-2678.

doi: 10.1080/07391102.2020.1752802. Epub 2020 Apr 16.

Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19

Nisha Muralidharan¹, R Sakthivel¹, D Velmurugan², M Michael Gromiha¹

Affiliations

Affiliations

¹ Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai, India.
² School of Bioengineering, Department of Biotechnology, SRM Institute of Science and Technology, Kattankulathur, Chennai, India.

PMID: 32248766
DOI: 10.1080/07391102.2020.1752802

Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19

Nisha Muralidharan et al. J Biomol Struct Dyn. 2021 Apr.

. 2021 Apr;39(7):2673-2678.

doi: 10.1080/07391102.2020.1752802. Epub 2020 Apr 16.

Authors

Nisha Muralidharan¹, R Sakthivel¹, D Velmurugan², M Michael Gromiha¹

Affiliations

¹ Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai, India.
² School of Bioengineering, Department of Biotechnology, SRM Institute of Science and Technology, Kattankulathur, Chennai, India.

PMID: 32248766
DOI: 10.1080/07391102.2020.1752802

No abstract available

PubMed Disclaimer

Similar articles

Lopinavir/ritonavir: Repurposing an old drug for HIV infection in COVID-19 treatment.
Magro P, Zanella I, Pescarolo M, Castelli F, Quiros-Roldan E. Magro P, et al. Biomed J. 2021 Mar;44(1):43-53. doi: 10.1016/j.bj.2020.11.005. Epub 2020 Nov 10. Biomed J. 2021. PMID: 33608241 Free PMC article. Review.
Understanding the binding mechanism for potential inhibition of SARS-CoV-2 Mpro and exploring the modes of ACE2 inhibition by hydroxychloroquine.
Choudhury M, Dhanabalan AK, Goswami N. Choudhury M, et al. J Cell Biochem. 2022 Feb;123(2):347-358. doi: 10.1002/jcb.30174. Epub 2021 Nov 6. J Cell Biochem. 2022. PMID: 34741481 Free PMC article.
Targeting the coronavirus SARS-CoV-2: computational insights into the mechanism of action of the protease inhibitors lopinavir, ritonavir and nelfinavir.
Bolcato G, Bissaro M, Pavan M, Sturlese M, Moro S. Bolcato G, et al. Sci Rep. 2020 Dec 1;10(1):20927. doi: 10.1038/s41598-020-77700-z. Sci Rep. 2020. PMID: 33262359 Free PMC article.
Comparative Antiviral Efficacy of Viral Protease Inhibitors against the Novel SARS-CoV-2 In Vitro.
Zhang L, Liu J, Cao R, Xu M, Wu Y, Shang W, Wang X, Zhang H, Jiang X, Sun Y, Hu H, Li Y, Zou G, Zhang M, Zhao L, Li W, Guo X, Zhuang X, Yang XL, Shi ZL, Deng F, Hu Z, Xiao G, Wang M, Zhong W. Zhang L, et al. Virol Sin. 2020 Dec;35(6):776-784. doi: 10.1007/s12250-020-00288-1. Epub 2020 Sep 10. Virol Sin. 2020. PMID: 32910347 Free PMC article.
Repositioning HIV protease inhibitors and nucleos(t)ide RNA polymerase inhibitors for the treatment of SARS-CoV-2 infection and COVID-19.
von Hentig N. von Hentig N. Eur J Clin Pharmacol. 2021 Sep;77(9):1297-1307. doi: 10.1007/s00228-021-03108-x. Epub 2021 Mar 4. Eur J Clin Pharmacol. 2021. PMID: 33660020 Free PMC article. Review.

See all similar articles

Cited by

Exploration of inhibitory action of Azo imidazole derivatives against COVID-19 main protease (M^pro): A computational study.
Chhetri A, Chettri S, Rai P, Sinha B, Brahman D. Chhetri A, et al. J Mol Struct. 2021 Jan 15;1224:129178. doi: 10.1016/j.molstruc.2020.129178. Epub 2020 Aug 31. J Mol Struct. 2021. PMID: 32904625 Free PMC article.
A computational study of potential therapeutics for COVID-19 invoking conceptual density functional theory.
Saloni, Kumari D, Ranjan P, Chakraborty T. Saloni, et al. Struct Chem. 2022;33(6):2195-2204. doi: 10.1007/s11224-022-02048-1. Epub 2022 Sep 8. Struct Chem. 2022. PMID: 36097582 Free PMC article.
Natural 7,8-secolignans from Schisandra sphenanthera fruit potently inhibit SARS-CoV-2 3CL^pro and inflammation.
Li B, Qiao L, Zhang J, Xiao Q, Liu J, Zhang B, Liu H. Li B, et al. J Tradit Complement Med. 2024 Jan 16;14(5):501-509. doi: 10.1016/j.jtcme.2024.01.005. eCollection 2024 Sep. J Tradit Complement Med. 2024. PMID: 39262656 Free PMC article.
COVID-19: Antiviral agents and enzyme inhibitors/receptor blockers in development.
Jogalekar MP, Veerabathini A, Patel AB. Jogalekar MP, et al. Exp Biol Med (Maywood). 2021 Jul;246(13):1533-1540. doi: 10.1177/1535370221999989. Epub 2021 Mar 23. Exp Biol Med (Maywood). 2021. PMID: 33757336 Free PMC article. Review.
Identification of potential inhibitors of SARS-CoV-2 main protease and spike receptor from 10 important spices through structure-based virtual screening and molecular dynamic study.
Sen D, Debnath P, Debnath B, Bhaumik S, Debnath S. Sen D, et al. J Biomol Struct Dyn. 2022 Feb;40(2):941-962. doi: 10.1080/07391102.2020.1819883. Epub 2020 Sep 18. J Biomol Struct Dyn. 2022. PMID: 32948116 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
Miscellaneous
- NCI CPTAC Assay Portal